Subscribe To
RHHBY / Roche open to big acquisitions 'if it makes scientific and financial sense' - CEO tells newspaper
RHHBY News
By Barrons
October 23, 2023
Roche Agrees $7.1 Billion for Drug Company
It will buy immunology company Telavant Holdings from Roivant Sciences and Pfizer. more_horizontal
By Proactive Investors
October 23, 2023
Roche splashes US$7.1 billion on new irritable bowel drug
Roche has agreed to pay US$7.1 billion for an early-stage inflammatory bowel disease treatment developed by US rivals Roivant and Pfizer. For its mon more_horizontal
By CNBC
October 23, 2023
Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings
Swiss health care company Roche announced it would acquire Telavant Holdings Monday, in a deal worth $7.1 billion. more_horizontal
By Reuters
October 23, 2023
Roche buys Telavant Holdings for $7.1 billion
Roche on Monday said it will buy Telavant, a developer of a new treatment for inflamatory bowel diseases, for an initial $7.1 billion from American bi more_horizontal
By CNBC
October 22, 2023
India is a ‘slow trundling elephant' but a viable alternative to China, says veteran investor David Roche
Veteran Investor David Roche said India has been aligning itself with the "democratic alliances" of the "richest and most vibrant economies" in the wo more_horizontal
By Zacks Investment Research
October 19, 2023
Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale
Roche (RHHBY) reports a sales decline in the first nine months of 2023 as COVID-19-test sales continue to dent its top line. Currency rate fluctuation more_horizontal
By Reuters
October 19, 2023
Roche's 9M sales down 6% on currency headwinds, drop in COVID sales
Roche said nine-month sales slipped 6% to 44.1 billion Swiss francs ($49.1 billion), hit by a sharp decline in sales of COVID-19 products and as a str more_horizontal
By Zacks Investment Research
October 16, 2023
Roche's (RHHBY) MS Drug Reduces Brain Lesions in Phase II Study
Roche (RHHBY) presents new data from a phase II study, which shows that fenebrutinib is brain penetrant and reduces brain lesions in people with relap more_horizontal